Fibroblast colony-forming cells with high sensitivity to serum mitogen(s) exist in bone marrow of patients with chronic myelocytic leukemia.

Abstract:

:Marrow fibroblast colony formation was studied in patients with myeloproliferative disorders, using human serum or platelet-derived growth factor plus plasma-derived serum as growth-stimulating factors. Colony numbers negatively correlated with the patient's age, but were not different from those of controls. However, both maximum and average cell numbers per colony were significantly increased in patients with chronic myelocytic leukemia (CML) as compared to controls. These results suggest that fibroblast colony-forming cells with high sensitivity to human serum mitogen(s) exist in a CML bone marrow. These may possibly be involved in one of the mechanism concerned with promoting fibrosis in this disease.

journal_name

Eur J Haematol

authors

Kimura A,Katoh O,Hyodo H,Kusumi S,Kuramoto A

doi

10.1111/j.1600-0609.1990.tb00397.x

subject

Has Abstract

pub_date

1990-05-01 00:00:00

pages

291-5

issue

5

eissn

0902-4441

issn

1600-0609

journal_volume

44

pub_type

杂志文章
  • Can t(8;21) oligoblastic leukemia be called a myelodysplastic syndrome?

    abstract::The new World Health Organization (WHO) classification of hematologic malignancies has incorporated t(8;21) myelodysplastic syndromes (MDS) according to the French-American-British classification into the category of acute myeloid leukemia (AML) with t(8;21)(q22;q22), while our knowledge about clinicopathological feat...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1034/j.1600-0609.2002.02770.x

    authors: Kaneda K,Kojima K,Takeuchi M,Takimoto H,Takaba S,Shinagawa K,Kobayashi H,Miyata A,Hara M,Tanimoto M

    更新日期:2002-09-01 00:00:00

  • High levels of serum prostate-specific antigen due to PSA producing follicular non-Hodgkin's lymphoma.

    abstract:OBJECTIVE:Both carcinoma of the prostate and non-Hodgkin's lymphoma are common in elderly patients. Measurement of serum prostate-specific antigen (PSA) is a frequently used tool to diagnose and monitor prostate carcinoma and is generally specific for diseases of the prostate. CASE:We describe a 68-yr-old patient with...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.2007.00883.x

    authors: Oosterheert JJ,Budel LM,Vos P,Wittebol S

    更新日期:2007-08-01 00:00:00

  • APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.

    abstract::BLyS and APRIL share two receptors - transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and B-cell maturation antigen (BCMA) - and BLyS binds to a third receptor, BAFF-R. We previously reported that TACI gene expression is a good indicator of a BLyS-binding receptor in human multipl...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.2009.01262.x

    authors: Moreaux J,Sprynski AC,Dillon SR,Mahtouk K,Jourdan M,Ythier A,Moine P,Robert N,Jourdan E,Rossi JF,Klein B

    更新日期:2009-08-01 00:00:00

  • Hydrocortisone modulates colony-stimulating activity produced by human bone marrow-derived adherent cells.

    abstract::In an attempt to clarify the significance of hydrocortisone (HC) in human long-term bone marrow cultures, the production of colony-stimulating activity (CSA) and colony-enhancing activity (CEA) by human bone marrow-derived adherent cells (MDAC) and the modulation by HC were examined. The CSA production by MDAC was dem...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.1988.tb00826.x

    authors: Hirata J,Kaneko S,Nishimura J,Motomura S,Ibayashi H

    更新日期:1988-03-01 00:00:00

  • Phenotype-genotype correlation in Sicilian patients with Hb H.

    abstract::We studied 15 Sicilian subjects with Hb H disease correlating clinical examinations with hematological and molecular data. Seven different alpha-tha1 mutations were identified: four deletion types (--MED --CAL, -alpha3.7, -alpha4.2) and three nondeletion types (alpha(Ncol)alpha, alpha(Hph)alpha, alphaCSalpha). All the...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1034/j.1600-0609.2000.065005306.x

    authors: Mirabile E,Samperi P,Di Cataldo A,Poli A,La Spina M,Schilirò G

    更新日期:2000-11-01 00:00:00

  • MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia.

    abstract:BACKGROUND:The single nucleotide polymorphism SNP309 with a change from T to G in the promoter region of the MDM2 gene is shown to increase the MDM2 protein levels and attenuate the p53 levels and associates with disease progression in several tumors. OBJECTIVE:In this study, the role of the polymorphism was investiga...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.2010.01470.x

    authors: Willander K,Ungerbäck J,Karlsson K,Fredrikson M,Söderkvist P,Linderholm M

    更新日期:2010-09-01 00:00:00

  • Treating Secondary Antibody Deficiency in Patients with Haematological Malignancy: European Expert Consensus.

    abstract:OBJECTIVES:Secondary antibody deficiency (SAD), associated with severe, recurrent or persistent infections, is common in patients with haematological malignancies (HM), but unifying guidance on immunoglobulin replacement therapy (IgRT) in these patients is lacking. We aimed to develop consensus statements for the use o...

    journal_title:European journal of haematology

    pub_type: 杂志文章,评审

    doi:10.1111/ejh.13580

    authors: Jolles S,Michallet M,Agostini C,Albert MH,Edgar D,Ria R,Trentin L,Lévy V

    更新日期:2021-01-16 00:00:00

  • Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.

    abstract:OBJECTIVE:Patients with hematologic malignancies are at substantial risk of developing invasive fungal infections (IFI) that are associated with substantial morbidity and mortality. This article reviews the epidemiology, risk factors, and efficacy of antifungal prophylaxis in patients with hematologic malignancies. ME...

    journal_title:European journal of haematology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1600-0609.2006.00805.x

    authors: Maertens J

    更新日期:2007-04-01 00:00:00

  • Cytoskeletal regulation of chemotactic receptors: molecular complexation of N-formyl peptide receptors with G proteins and actin.

    abstract::Signal transduction via receptors for N-formylmethionyl peptide chemoattractants (FPR) on human neutrophils is a highly regulated process. It involves direct interaction of receptors with heterotrimeric G-proteins and may be under the control of cytoskeletal elements. Evidence exists suggesting that the cytoskeleton a...

    journal_title:European journal of haematology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1600-0609.1993.tb01610.x

    authors: Jesaitis AJ,Klotz KN

    更新日期:1993-11-01 00:00:00

  • External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients.

    abstract:OBJECTIVES:In patients with essential thrombocythemia (ET), vascular complications contribute to both morbidity and mortality. To better predict the occurrence of thrombotic events, an International Prognostic Score of thrombosis for ET (IPSET-thrombosis) was recently developed. We hereby presented an external validati...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/ejh.12275

    authors: Fu R,Xuan M,Lv C,Zhang L,Li H,Zhang X,Zhang D,Sun T,Xue F,Liu X,Liang H,Zhang L,Yang R

    更新日期:2014-06-01 00:00:00

  • Acute tumour lysis syndrome following a single-dose corticosteroid in children with acute lymphoblastic leukaemia.

    abstract::Acute tumour lysis syndrome (ATLS) is a well recognised complication of treatment of a variety of malignant disorders. It commonly occurs in patients with non-Hodgkin's lymphoma (NHL) and acute lymphoblastic leukaemia (ALL) with the administration of combined cytotoxic chemotherapy. It is rarely reported after single-...

    journal_title:European journal of haematology

    pub_type: 杂志文章,评审

    doi:10.1034/j.1600-0609.2001.066006404.x

    authors: Duzova A,Cetin M,Gümrük F,Yetgin S

    更新日期:2001-06-01 00:00:00

  • Sivelestat relieves respiratory distress refractory to dexamethasone in all-trans retinoic acid syndrome: a report of two cases.

    abstract::Treatment with all-trans retinoic acid (ATRA) improves the prognosis of patients with acute promyelocytic leukemia (APL), but ATRA syndrome may occur as a possible fatal side effect, especially in cases refractory to medication or involving pulmonary hemorrhage. We describe two patients with APL who suffered from intr...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.0902-4441.2006.t01-1-EJH2852.x

    authors: Kawasaki K,Akaike H,Miyauchi A,Ouchi K

    更新日期:2006-11-01 00:00:00

  • Effectiveness of propagermanium treatment in multiple myeloma patients.

    abstract::Interferon (IFN) is one of several drugs effective in treating multiple myeloma (MM), and propagermanium is an IFN inducer. We report on 10 MM patients who were treated with propagermanium at doses from 10 to 40 mg. Two patients achieved complete remission (CR), two patients achieved partial remission (PR), and the co...

    journal_title:European journal of haematology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1600-0609.2004.00330.x

    authors: Tsutsumi Y,Tanaka J,Kanamori H,Musashi M,Minami H,Fukushima A,Yamato H,Ehira N,Kawamura T,Obara S,Ogura N,Asaka M,Imamura M,Masauzi N

    更新日期:2004-12-01 00:00:00

  • Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications.

    abstract::Angiogenesis is critical for the clinical progression of haematopoietic malignancies and depends on angiogenic factors. Angiogenin is a powerful factor produced by neoplastic cells and host microenvironment. High levels of soluble angiogenin (sAng) correlate with a poor prognosis in patients affected by acute myeloid ...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.2004.00253.x

    authors: Musolino C,Alonci A,Bellomo G,Loteta B,Quartarone E,Gangemi D,Massara E,Calabrò L

    更新日期:2004-06-01 00:00:00

  • Leukocyte-depleted blood components prevent platelet refractoriness in patients with acute myeloid leukemia.

    abstract::Platelet refractoriness arising from HLA immunization develops in 20-50% of multitransfused patients with hematologic malignancies. We retrospectively analyzed the efficiency of leukocyte-depleted blood components in preventing refractoriness in 140 adult patients with acute myeloid leukemia (AML), treated according t...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.1994.tb01872.x

    authors: Oksanen K

    更新日期:1994-08-01 00:00:00

  • A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5.

    abstract::The Hermansky-Pudlak syndrome (HPS) is a rare genetically heterogeneous autosomal recessive disorder, characterized by tyrosinase-positive oculocutaneous albinism, platelet dysfunction and lysosomal ceroid lipofuscin storage. This is caused by defects in lysosome-related organelles. In humans eight different types of ...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.2007.01024.x

    authors: Korswagen LA,Huizing M,Simsek S,Janssen JJ,Zweegman S

    更新日期:2008-04-01 00:00:00

  • Impact of atrial fibrillation on platelet gene expression.

    abstract:AIMS:Platelets retain cytoplasmic messenger RNA and are capable of protein biosynthesis. Several diseases are known to impact the platelet transcriptome but the effect of non-valvular atrial fibrillation (NVAF) on platelet RNA transcript is essentially unknown. The aim of this study was to evaluate the impact of NVAF o...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/ejh.12879

    authors: Wysokinski WE,Tafur A,Ammash N,Asirvatham SJ,Wu Y,Gosk-Bierska I,Grill DE,Slusser JP,Mruk J,McBane RD

    更新日期:2017-06-01 00:00:00

  • Disseminated intravascular coagulation in acute leukemia: clinical and laboratory features at presentation.

    abstract:BACKGROUND:Although there are two major scoring systems for the clinical diagnosis of disseminated intravascular coagulation (DIC), the validity of these systems for leukemia-associated DIC remains to be confirmed. METHODS:By analyzing 125 newly diagnosed acute leukemia patients, we investigated clinical and laborator...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.2006.00711.x

    authors: Yanada M,Matsushita T,Suzuki M,Kiyoi H,Yamamoto K,Kinoshita T,Kojima T,Saito H,Naoe T

    更新日期:2006-10-01 00:00:00

  • Cardiac function during iron chelation therapy in adult non-thalassaemic patients with transfusional iron overload.

    abstract::It is well-documented that iron chelation by desferrioxamine protects/improves the cardiac function in blood transfusion-dependent children suffering from beta-thalassaemia. In patients who do not become dependent upon blood transfusion until adulthood (ANT-patients), iron chelation by desferrioxamine may affect the c...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.1997.tb00981.x

    authors: Jensen PD,Olsen N,Bagger JP,Jensen FT,Christensen T,Ellegaard J

    更新日期:1997-10-01 00:00:00

  • Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders.

    abstract::The candidate tumour suppressor gene MMAC1/PTEN located at chromosome 10q23.3 has been reported to be frequently mutated in a number of solid tumours. Less is known about its status in leukaemia. In the present study we first analysed 13 leukaemia cell lines for mutations and homozygous deletions in MMAC1/PTEN using P...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1034/j.1600-0609.2000.90181.x

    authors: Aggerholm A,Grønbaek K,Guldberg P,Hokland P

    更新日期:2000-08-01 00:00:00

  • A novel gene STORP (STOmatin-Related Protein) is localized 2 kb upstream of the promyelocytic gene on chromosome 15q22.

    abstract::We generated a 100-kb map of the region 5' of the PML (promyelocytic leukemia) gene on human chromosome 15q22 and identified a new gene provisionally named STORP for stomatin-related protein. The STORP gene is positioned 2 kb upstream of the PML gene in a head-to-head configuration, and contains 7 exons spanning a gen...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1034/j.1600-0609.2000.90054.x

    authors: Gilles F,Glenn M,Goy A,Remache Y,Zelenetz AD

    更新日期:2000-02-01 00:00:00

  • Early establishment of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation in comparison with allogeneic bone marrow transplantation.

    abstract::To characterize the process of the establishment of complete chimerism after allogeneic peripheral blood stem cell transplantation (allo-PBSCT), we determined the origin of leukocytes in peripheral blood (PB) obtained from 23 patients in the very early period after allo-PBSCT using amplification of mini- or microsatel...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.1999.tb01756.x

    authors: Nakao S,Zeng W,Yamazaki H,Wang H,Takami A,Sugimori N,Miura Y,Shiobara S,Matsuda T,Shinagawa Y,Harada M

    更新日期:1999-04-01 00:00:00

  • The hematologic consequences of obesity.

    abstract::The prevalence of obesity is increasing and progressively influencing physician-patient interactions. While there is a sizable amount of data demonstrating that obesity is a state of low-grade inflammation, to our knowledge, there is no single review summarizing its effects on hematologic parameters and thrombotic ris...

    journal_title:European journal of haematology

    pub_type: 杂志文章,评审

    doi:10.1111/ejh.13560

    authors: Purdy JC,Shatzel JJ

    更新日期:2020-12-03 00:00:00

  • Neurological symptoms in essential thrombocythemia: impact of JAK2V617F mutation and response to therapy.

    abstract::Patients with essential thrombocythemia (ET) often suffer from neurological symptoms (NS) not ever resulting from previous thrombotic cerebral events (TCE). We reported NS occurred in 282 patients, in order to identify the factors influencing ET-related NS in the absence of TCE, and the response to therapy. Overall, 1...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/ejh.12638

    authors: Aroldi A,Cecchetti C,Colombo A,Cattaneo L,Pioltelli PE,Pogliani EM,Elli EM

    更新日期:2016-06-01 00:00:00

  • FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.

    abstract::Reduced-intensity conditioning regimens have demonstrated lower toxicity but increased relapse rates in the context of allogeneic hematopoietic stem cell transplantation (aSCT) for patients with acute myelogenous leukemia (AML). The FLAMSA- reduced-intensity conditioning (RIC) regimen, combining a cytoreductive and a ...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/ejh.12615

    authors: Holtick U,Shimabukuro-Vornhagen A,Chakupurakal G,Theurich S,Leitzke S,Burst A,Hallek M,von Bergwelt-Baildon M,Scheid C,Chemnitz JM

    更新日期:2016-05-01 00:00:00

  • Challenges of multiple mutations in individual patients with haemophilia.

    abstract::Multiple mutations in the same gene within a haemophilia family are being increasingly reported and raise many issues with regard to the specificity of the mutations in causing the disease. In a proportion of families with multiple mutations, discordant phenotypic severity is often observed among the affected members....

    journal_title:European journal of haematology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1600-0609.2010.01564.x

    authors: Shetty S,Bhave M,Ghosh K

    更新日期:2011-03-01 00:00:00

  • Rapid remineralization of multiple disseminated bone lesions after high-dose cytarabine in a patient with isolated myeloid sarcoma.

    abstract::Isolated myeloid sarcoma is a rare presentation of acute myeloid leukemia. There are limited data available concerning the prognostic relevance and the right treatment strategy for this clinical scenario. Here, we report a case of acute myeloid leukemia with extensive lesions and fractures in multiple bones in a 64-yr...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/ejh.12254

    authors: Brähler S,Thielen I,Schwabe H,Engels M,Kreuzer KA,Wolf J,Ansén S

    更新日期:2014-06-01 00:00:00

  • Central nervous system myelomatosis: review of the literature.

    abstract::Involvement of the central nervous system (CNS) in multiple myeloma (MM) is very uncommon; it has been observed in approximately 1% of the MM patients. This review summarizes the clinical and laboratory characteristics and treatment modalities of 109 patients with CNS myelomatosis (CNS MM) reported in the literature. ...

    journal_title:European journal of haematology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1600-0609.2007.00956.x

    authors: Nieuwenhuizen L,Biesma DH

    更新日期:2008-01-01 00:00:00

  • Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma.

    abstract::Many cost analyses of stem-cell transplantations are available, which is in sharp contrast to the level of cost analyses on first-line chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). Given the scarcity of cost analyses of first-line chemotherapy for NHL, it is difficult to assess the economic impact of upcom...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1034/j.1600-0609.2002.02772.x

    authors: van Agthoven M,Faber LM,Uyl-de Groot CA,Sonneveld P,Verdonck LF,Willemze R,Kluin-Nelemans JC,Löwenberg B,Huijgens PC

    更新日期:2002-10-01 00:00:00

  • An Arg545----Cys545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease.

    abstract::Type IIB is a special variant of von Willebrand's disease, characterized by an abnormal von Willebrand factor which shows an increased interaction with platelets. This interaction sometimes causes platelet aggregation and thrombocytopenia in vivo. It involves the glycoprotein-Ib (GPIb) receptor on platelets and corres...

    journal_title:European journal of haematology

    pub_type: 杂志文章

    doi:10.1111/j.1600-0609.1991.tb01858.x

    authors: Donnér M,Andersson AM,Kristoffersson AC,Nilsson IM,Dahlbäck B,Holmberg L

    更新日期:1991-11-01 00:00:00